In Depth 19 Jan 2024
Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases?
Check out our latest article as we explore some of the latest research around using CRISPR technology to treat neurodegenerative diseases.
- Latest Posts
Podcast 19 Jan 2024
Epigenetic editing – the power of CRISPR without cutting DNA
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]
In Depth 18 Jan 2024
GLP-1 agonists: what’s the hype about?
GLP-1 agonists have been on the radar for a while to treat diabetes and obesity. And of late, there has been renewed interest in these drugs.
News and Trends 18 Jan 2024
2024 J.P. Morgan Healthcare Conference: key takeaways from the largest biotech gathering of the year
Here are some of the key takeaways from the JPM Healthcare Conference that lay the groundwork for what we can expect in 2024.
In Depth 17 Jan 2024
Bladder cancer treatment: where are we standing?
Bladder cancer is the 10th most common cancer. Delve into the most promising strides in bladder cancer treatment.
Best in Biotech 16 Jan 2024
Five biotech companies taking Florida by storm
Check out five of the top Florida companies taking the state’s biotech industry by storm with their innovative technologies.
ADVERTISEMENT
ADVERTISEMENT
Mastering biologics tech transfer: key success factors
Unlock the secrets of efficient tech transfers for biologics, and explore critical stages and success factors.
News and Trends 12 Jan 2024
AI and a brain organoid: can this combo take on supercomputers?
Explore the groundbreaking fusion of brain organoids and AI in the creation of Brainoware, the world’s first biohybrid computer.
Podcast 12 Jan 2024
Could natural killer cells transform Alzheimer’s treatment?
Join Dr. Paul Song, CEO of NKGen Biotech, in a podcast exploring the revolutionary use of NK cells for Alzheimer’s treatment.
Best in Biotech 11 Jan 2024
Ten NK cell therapy companies to look out for this year
As biotechs raise funding to advance their NK cell therapy candidates in the clinic, here are ten companies in the space to watch out for.
In Depth 10 Jan 2024
The biggest private biotech investments in December 2023
The companies Tome Biosciences, Bicara Therapeutics, and Seismic Therapeutic bagged the biggest biotech investments in December 2023. Around the world, food, immunology, oncology, central nervous system (CNS), and biofermentation players attracted the biggest funding rounds overall. Although December is generally a quiet time for biotech fundraising, there were still some big rounds raised in the […]
Best in Biotech 9 Jan 2024
Four Pune-based biotech companies you should know about
Explore Pune’s dynamic biotech landscape and delve into the innovative work of the city’s most prominent biotech companies!
ADVERTISEMENT
